Cocrystal Pharma, Inc. - Common Stock (COCP)

Cocrystal Pharma Inc. is a biotechnology company focused on the development of innovative antiviral therapies to treat various viral infections

The company utilizes its proprietary drug discovery platform to create novel compounds aimed at inhibiting viral replication and targeting specific viral targets. Cocrystal Pharma is particularly engaged in research related to hepatitis and influenza, striving to address unmet medical needs in the field of infectious diseases. Through its scientific advancements and strategic partnerships, the company aims to deliver effective treatments that can significantly improve patient outcomes.